sfRowasa Sulfite-Free Formulation 4 g/60mL
mesalamine · SUSPENSION · Viatris Specialty LLC
Sfrowasa is a rectal suspension containing mesalamine, a medication used to treat ulcerative colitis and other inflammatory bowel conditions. This sulfite-free formulation delivers the active ingredient directly to the colon to help reduce inflammation.
Key Facts
- Brand Name
- sfRowasa Sulfite-Free Formulation
- Generic Name
- mesalamine
- NDC Code (Product)
0037-0022- Manufacturer
- Viatris Specialty LLC
- Strength
- 4 g/60mL
- Dosage Form
- SUSPENSION
- Route
- RECTAL
- Marketing Status
- Application #
- NDA019618
- Drug Class
- Aminosalicylate [EPC]
- Marketing Start
- 03/24/2016
Recall History
No Recall HistoryFrequently Asked Questions
What is sfRowasa Sulfite-Free Formulation used for?
Sfrowasa is a rectal suspension containing mesalamine, a medication used to treat ulcerative colitis and other inflammatory bowel conditions. This sulfite-free formulation delivers the active ingredient directly to the colon to help reduce inflammation.
Is sfRowasa Sulfite-Free Formulation a controlled substance?
sfRowasa Sulfite-Free Formulation is not classified as a controlled substance by the DEA.
What is the generic name for sfRowasa Sulfite-Free Formulation?
The generic name for sfRowasa Sulfite-Free Formulation is mesalamine. There are 12 other brand versions of mesalamine.
What is the NDC code for sfRowasa Sulfite-Free Formulation 4 g/60mL?
The NDC (National Drug Code) for sfRowasa Sulfite-Free Formulation 4 g/60mL is 0037-0022, listed by Viatris Specialty LLC.